UA86516C2 - VETERINARY biologically active additive of liposomal form and method for reparative therapy in hepatology - Google Patents
VETERINARY biologically active additive of liposomal form and method for reparative therapy in hepatologyInfo
- Publication number
- UA86516C2 UA86516C2 UAA200710252A UAA200710252A UA86516C2 UA 86516 C2 UA86516 C2 UA 86516C2 UA A200710252 A UAA200710252 A UA A200710252A UA A200710252 A UAA200710252 A UA A200710252A UA 86516 C2 UA86516 C2 UA 86516C2
- Authority
- UA
- Ukraine
- Prior art keywords
- biologically active
- mix
- active additive
- veterinary
- liposomal form
- Prior art date
Links
Abstract
The invention relates to veterinary medicine, namely, to methods for activation of reparative processes in liver at development of inflammatory, distrophic and other pathological changes, which provides the use of liposomal form of biologically active additive of hepatoprotective and hepatoregenerative action in hepatology for prevention and treatment of hepatites and hepatoses of various aetiology in animals, as well as an agent for "medicamentous background" when using preparations with hepatotoxic activity.The invention consists in that the veterinary biologically active additive of liposomal form contains lipid mix of lubricator, mix of unsaturated fatty acids and vitamins А and Е, has liquid liposomal form (solvent phosphate buffer with pН 7.5) and contains lipid mix of lubricator, which, preferable, consists of phospholipids, and a mix of unsaturated fatty acids (70 % linolenic acid, the rest are linolic, oleic and other acids), in the folowing ratio: lipid mix of lubricator: mix of unsaturated fatty acids - 0.7- 0.9:0.49-0.63 and vitamins of liposoluble group, namely:-tocopherol – 42.0-56.0 mg and retinol acetate - 14000-19600 UO calculated for of biologically active additive. A method for reparative therapy in hepatitis and fatty hepatosis is also claimed, which comprises the complex oral administration of veterinary biologically active additive of the liposomal additive according to the invention, which is given orally to animals, patients with hepatitis and fatty hepatosis, in a dose of 0.9-1.4 ml per of body weight after minimal period of use from 3 weeks to 3 months.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| UAA200710252A UA86516C2 (en) | 2007-09-14 | 2007-09-14 | VETERINARY biologically active additive of liposomal form and method for reparative therapy in hepatology |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| UAA200710252A UA86516C2 (en) | 2007-09-14 | 2007-09-14 | VETERINARY biologically active additive of liposomal form and method for reparative therapy in hepatology |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UA86516C2 true UA86516C2 (en) | 2009-04-27 |
Family
ID=50620063
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UAA200710252A UA86516C2 (en) | 2007-09-14 | 2007-09-14 | VETERINARY biologically active additive of liposomal form and method for reparative therapy in hepatology |
Country Status (1)
| Country | Link |
|---|---|
| UA (1) | UA86516C2 (en) |
-
2007
- 2007-09-14 UA UAA200710252A patent/UA86516C2/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1049334C (en) | Fatty acid treatment | |
| JP4151853B2 (en) | A therapeutic agent containing eicosapentaenoic acid and / or stearidonic acid | |
| Gura et al. | Use of a fish oil-based lipid emulsion to treat essential fatty acid deficiency in a soy allergic patient receiving parenteral nutrition | |
| TWI285549B (en) | Therapeutic combinations of fatty acids | |
| TWI386209B (en) | Emulsion composition comprising prostaglandin e1 | |
| SK14502003A3 (en) | Coenzyme Q and eicosapentaenoic acid | |
| JP2005531595A (en) | Topical drug delivery using phosphatidylcholine | |
| JPH02243623A (en) | Therapy by fatty acid and aomposition thereof | |
| US20030232097A1 (en) | Oily wax matrix suspension formulation comprising ibuprofen free acid and potassium salt of ibuprofen | |
| JP2005519985A5 (en) | ||
| AU2002309038B2 (en) | Compositions for transmucosal administration containing coenzyme Q as the active ingredient | |
| WO2011091019A1 (en) | Methods and compositions for treating and preventing parenteral nutrition associated liver disease | |
| JPH05178744A (en) | Method for medical treatment using fatty acid | |
| CA1287297C (en) | Iron - containing compositions and method for treatment of cancer | |
| JPH09509139A (en) | Butyrate ester cell differentiation drug | |
| Schröder et al. | Tributyrin induces growth inhibitory and differentiating effects on HT-29 colon cancer cells in vitro. | |
| AU2008301694B2 (en) | Compositions Containing Sesamin-Class Compound(s) and Arachidonic Acid Class Compound(s) | |
| FR2904554A1 (en) | CYTOTROPIC HETEROGENEOUS MOLECULAR LIPIDS (LMHC), PREPARATION METHOD, AND METHODS FOR TREATING MULTIPLE CANCER PROTECTIVE PATIENTS | |
| JPH0399013A (en) | Therapy with fatty acid | |
| ES2404656T3 (en) | Compositions comprising an oil-in-water emulsion containing conjugated linoleic acid | |
| EP0369437B1 (en) | Motilin preparation | |
| UA86516C2 (en) | VETERINARY biologically active additive of liposomal form and method for reparative therapy in hepatology | |
| JPH0759540A (en) | Arachidonic acid-containing healthy food | |
| JPH06271464A (en) | Arachidonic acid-containing composition for prevention or improvement of alimentary disorder | |
| JP3947322B2 (en) | Pharmaceutical composition and health food containing polyunsaturated fatty acid |